Infectious diseases

RECOVERY trial investigators warned against including dexamethasone at start

The researchers leading the RECOVERY trial were told by many people they should not have included dexamethasone in the study when it launched at the start of the first wave of COVID-19, delegates at the British Thoracic Society Winter meeting heard during a symposium on the conduct of trials during the pandemic. Yet less than ...

Already a member?

Login to keep reading.

© 2022 the limbic